International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders
By A. Dispenzieri, R. Kyle, G. Merlini, J. Miguel, H. Ludwig, R. Hájek, A. Palumbo, S. Jagannath, J. Bladé, S. Lonial and 23 more. Leukemia, 2009
801 citations recorded by the source corpus.
Subfields: Genetics, Hematology, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/df03ff6884437881e7ba77545b54c762aadca650
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Genetics
In Hematology
In Molecular Biology
Citations in the corpus
- Multiple myeloma: 2022 update on diagnosis, risk stratification, and management (2022, background): “The serum FLC assay is particularly useful in patients who lack a measurable M protein, provided the FLC ratio is abnormal and the involved FLC level is ≥100 mg/L.(32) Urine protein electrophoresis is recommended at least once every 3–6 months, to follow the urine M protein level as well as to detec”
- Multiple myeloma: 2020 update on diagnosis, risk‐stratification and management (2020, background): “The serum FLC assay is particularly useful in patients who lack a measurable M protein, provided the FLC ratio is abnormal and the involved FLC level is ≥100 mg/L.(29) Urine protein electropho-”